Just over two years ago, the former government contractor EG&G acquired PerkinElmer’s analytical instruments business, and with it the rights to PerkinElmer’s name. The new identity, company officials said at the time, symbolized the company’s potential as a player in the life sciences.
Now, marking the extent of its transformation, the new PerkinElmer wants to extend its reach into proteomics.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.
Try GenomeWeb Premium now.
Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
